Eton Pharmaceuticals Inc (ETON) shares recently traded at $58.86, surpassing the average analyst 12-month target price of $52.70. Analysts report mixed targets, with predictions ranging from a low of $36.50 to a high of $65.00, and a standard deviation of $13.37 among estimates.
As of now, the ratings for Eton Pharmaceuticals show 5 “Strong Buy” recommendations, while there is 1 “Strong Sell.” The average rating stands at 1.67 on a scale from 1 (Strong Buy) to 5 (Strong Sell). Investors may need to reassess their positions, weighing whether the stock may continue to rise or if valuations have become overstretched.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
